Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
I-040202 in acute open tibial shaft fractures
2006-005093-40Phase 2Completed
- Sponsor
- Kuros Biosciences
- Start
- Jun 2007
- Modality
- Peptides, Hydrogel Systems → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial in Open Tibial Shaft Fracture comparing Standard of care alone with Standard of care plus I-040202 (2 arms). Primary endpoint: Proportion of patients healed at 6 months. Started Jun 2007; status: completed.
02
Drugs
KUR-113
03
Conditions
Open Tibial Shaft Fracture
Beyond the preview
Go deeper on 2006-005093-40.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-005093-40.